메뉴 건너뛰기




Volumn 2, Issue 2, 2014, Pages 105-106

It takes more than one CAMERA to study cardiovascular protection by metformin

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; METFORMIN;

EID: 84893382603     PISSN: 22138587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-8587(13)70207-9     Document Type: Letter
Times cited : (4)

References (5)
  • 1
    • 84894900806 scopus 로고    scopus 로고
    • Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial
    • published online Nov 7.
    • Preiss D, Lloyd SM, Ford I, et al. Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes Endocrinol 2013, published online Nov 7. 10.1016/S2213-8587(13)70152-9.
    • (2013) Lancet Diabetes Endocrinol
    • Preiss, D.1    Lloyd, S.M.2    Ford, I.3
  • 3
    • 67650921900 scopus 로고    scopus 로고
    • Metformin prevents myocardial reperfusion injury by activating the adenosine receptor
    • Paiva M, Riksen NP, Davidson SM, et al. Metformin prevents myocardial reperfusion injury by activating the adenosine receptor. J Cardiovasc Pharmacol 2009, 53:373-378.
    • (2009) J Cardiovasc Pharmacol , vol.53 , pp. 373-378
    • Paiva, M.1    Riksen, N.P.2    Davidson, S.M.3
  • 4
    • 61949300140 scopus 로고    scopus 로고
    • Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure
    • Gundewar S, Calvert JW, Jha S, et al. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ Res 2009, 104:403-411.
    • (2009) Circ Res , vol.104 , pp. 403-411
    • Gundewar, S.1    Calvert, J.W.2    Jha, S.3
  • 5
    • 84858411451 scopus 로고    scopus 로고
    • Targeting adenosine receptors in the development of cardiovascular therapeutics
    • Riksen NP, Rongen GA Targeting adenosine receptors in the development of cardiovascular therapeutics. Expert Rev Clin Pharmacol 2012, 5:199-218.
    • (2012) Expert Rev Clin Pharmacol , vol.5 , pp. 199-218
    • Riksen, N.P.1    Rongen, G.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.